首頁
瀏覽量: 285
- 產(chǎn)品名稱： Research Grade Caplacizumab ( 卡拉西單抗 )
- 產(chǎn)品貨號(hào)： CSD00272
- 貨期： 現(xiàn)貨
- 價(jià)格與訂購： 2480
- 數(shù)量：
庫存： 100
- 規(guī)格： 100μg
- 產(chǎn)品信息
- 如何訂購
貨號(hào)（Catalog No.）
CSD00272
通用名INN
Caplacizumab
純度(Purity)
>95%
電泳圖（SDS-PAGE image）
icon
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內(nèi)毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Caplacizumab, firstly called ALX-0081, is a humanized single-variable-domain immunoglobulin consisting of two identical humanized building blocks genetically linked by a three-alanine linker. Caplacizumab was developed by Ablynx, a Sanofi company and FDA approved on February 6, 2019,6 and approved previously by the EU in October 2018 as a combination therapy with plasma exchange and immunosuppression.
別名(Alternative names)
ALX-0081,PMP12A2h1-linker AAA-PMP12A2h1,caplacizumab-yhdp
靶點(diǎn);物種(Specificity target name;species)
VWF A1 domain[Homo sapiens]
種類(Species)
Humanized
受體鑒定(Receptor identification)
VH-VH
分子量(MV)
27880.0 Da
CAS
915810-67-2
存儲(chǔ)條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
地 址：
產(chǎn)品銷售：
E - mail ：
郵 編：
Amily
